XML 15 R4.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Operations - USD ($)
 12 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Income Statement [Abstract]    
Revenues
Operating Expenses:    
Research and development 17,655,482 12,240,503
General and administrative 11,754,609 9,836,412
Stock-based compensation – general and administrative 3,905,954 1,454,979
Total Operating Expenses 33,316,045 23,531,894
Operating Loss (33,316,045) (23,531,894)
Other Income (Expense):    
Interest income 251,399 261,825
Gain on forgiveness of note payable - Paycheck Protection Program and accrued interest   166,557
Other income 59,917
Interest expense (10,839)
Total Other Income, Net 251,399 477,460
Loss before Income Taxes (33,064,646) (23,054,434)
Income tax expense 576,000  
Net Loss (33,640,646) (23,054,434)
Deemed dividend on warrant extension 1,450,876
Net Loss Applicable to Common Stockholders $ (33,640,646) $ (24,505,310)
Net Loss Per Share Applicable to Common Stockholders - Basic (in Dollars per share) $ (0.23) $ (0.23)
Weighted Average Common Shares Outstanding    
Weighted average common shares outstanding - Basic (in Shares) 146,082,399 108,599,080